Search Results - "Fillit H"

Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease.

Authors: Laskowitz, Daniel T. Fillit, H. Yeung, N. et al.

Source: Acta Neurologica Scandinavica: Supplementum. Aug2006 Supplement 185, Vol. 114, p15-20. 6p. 1 Diagram, 1 Chart, 3 Graphs.

Subjects: Apolipoproteins, Central nervous system infections, Encephalitis, Neurodegeneration, Peptides

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

New directions in neuroprotection: Basic mechanisms, molecular targets and treatment strategies.

Authors: Refolo, L. M. Fillit, H. M.

Source: Journal of Alzheimer's Disease. 2004 Supplement, Vol. 6, pS1-S2. 2p.

Studies of hospital social stays in the frail elderly and their relationship to the intensity of social work intervention.

Authors: Fillit H Howe JL Fulop G et al.

Source: Social Work in Health Care. 1992, Vol. 18 Issue 1, p1-22. 22p.

Serial studies on circulating immune complexes in post-streptococcal sequelae.

Authors: van de Rijn, I. Fillit, H. Brandeis, W. E. et al.

Source: Clinical & Experimental Immunology. Dec1978, Vol. 34 Issue 3, p318-325. 8p.

'Our parents, ourselves'.

Authors: Turiel JS Fillit H

Source: JAMA: Journal of the American Medical Association. 11/1/2006, Vol. 296 Issue 17, p2092-2093. 2p.

P3-408 Healthcare costs of vascular dementia in community-dwelling patients

Authors: Hill, J. Fillit, H. Futterman, R. et al.

Source: Neurobiology of Aging. Jul2004 Supplement 2, Vol. 25, pS471-S471. 1p.

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.

Authors: Liss, J. L. Seleri Assunção, S. Cummings, J. et al.

Source: Journal of Internal Medicine. Aug2021, Vol. 290 Issue 2, p310-334. 25p.

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors: Shumaker SA Legault C Kuller L et al.

Source: JAMA: Journal of the American Medical Association. 6/23/2004, Vol. 291 Issue 24, p2947-2958. 12p.

Masculine vitality: pros and cons of testosterone in treating the andropause.

Authors: Asthana S Bhasin S Butler RN et al.

Source: Journals of Gerontology Series A: Biological Sciences & Medical Sciences. May2004, Vol. 59 Issue 5, p461-465. 5p.

An Update on Healthcare Resource Use and Economic Burden In Alzheimer's Disease In The United States (Us) From A Medicare Sample Analysis.

Authors: Coste, F Neumann, PJ Xie, L et al.

Source: Value in Health. Nov2015, Vol. 18 Issue 7, pA754-A754. 1p.

Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.

Authors: Wang L Hu W Dong F et al.

Corporate Authors: Wang L Hu W Dong F et al.

Source: GeroScience [Geroscience] 2025 Aug; Vol. 47 (4), pp. 5619-5634. Date of Electronic Publication: 2025 Jan 31.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE

Alzheimer Combination Therapies: Overview and Scenarios.

Authors: Cummings JL Burstein AH Fillit H

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100328. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Add-on combination therapy with monoclonal antibodies: Implications for drug development.

Authors: Cummings J Burstein AH Fillit H

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100359. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches.

Authors: Bereczki E Mangialasche F Barbera M et al.

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100367. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation.

Authors: Corbett A Sultana J Stych K et al.

Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Nov 18; Vol. 17 (1), pp. 237. Date of Electronic Publication: 2025 Nov 18.

Publication Type: Journal Article; Review; Consensus Statement

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE

Implementing early detection of cognitive impairment in primary care to improve care for older adults.

Authors: Fowler NR Partrick KA Taylor J et al.

Source: Journal of internal medicine [J Intern Med] 2025 Jul; Vol. 298 (1), pp. 31-45. Date of Electronic Publication: 2025 May 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force.

Authors: Angioni D Middleton L Bateman R et al.

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Jun; Vol. 12 (6), pp. 100163. Date of Electronic Publication: 2025 Apr 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Disease progression and costs at the 3-year follow-up of the GERAS-US study.

Authors: Chandler JM Rentz DM Zagar A et al.

Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2023 Apr 19; Vol. 15 (2), pp. e12430. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE